Ocularly applied non-steroidal anti-inflammatory drugs may cause increased bleeding of ocular tissues (including hyphemas) in conjunction with ocular surgery.
Nepafenac is a non-steroidal anti-inflammatory prodrug (NSAID) usually sold as a prescription eye drop. It is used to treat pain and inflammation associated with cataract surgery.
Fitur visualisasi ini dikembangkan menggunakan pendekatan Graph Theory untuk memetakan hubungan polifarmasi dan molekuler. Entitas (Obat, Target, Gen) direpresentasikan sebagai Simpul (Nodes), sedangkan hubungan biologisnya sebagai Sisi (Edges).
drugbank-id dan name pada skema XML DrugBank.targets/target yang memuat polipeptida sasaran.gene-name dan varian snp-effects.Tata letak grafik menggunakan algoritma Force-Directed Graph (Barnes-Hut). Model fisika ini menerapkan gaya tolak-menolak antar simpul (Gravitasi: -3000) agar tidak tumpang tindih, serta gaya pegas (Spring: 0.04) pada garis penghubung untuk fleksibilitas interaksi.
| Aminosalicylic acid | The therapeutic efficacy of Aminosalicylic acid can be decreased when used in combination with Nepafenac. |
| Mesalazine | The risk or severity of nephrotoxicity can be increased when Mesalazine is combined with Nepafenac. |
| Sulfasalazine | The therapeutic efficacy of Sulfasalazine can be decreased when used in combination with Nepafenac. |
| Diflunisal | The therapeutic efficacy of Diflunisal can be decreased when used in combination with Nepafenac. |
| Acetylsalicylic acid | The therapeutic efficacy of Acetylsalicylic acid can be decreased when used in combination with Nepafenac. |
| Balsalazide | The therapeutic efficacy of Balsalazide can be decreased when used in combination with Nepafenac. |
| Olsalazine | The risk or severity of nephrotoxicity can be increased when Nepafenac is combined with Olsalazine. |
| Bismuth subsalicylate | The therapeutic efficacy of Bismuth subsalicylate can be decreased when used in combination with Nepafenac. |
| Dersalazine | The therapeutic efficacy of Dersalazine can be decreased when used in combination with Nepafenac. |
| Phenyl aminosalicylate | The therapeutic efficacy of Phenyl aminosalicylate can be decreased when used in combination with Nepafenac. |
| Methyl salicylate | The therapeutic efficacy of Methyl salicylate can be decreased when used in combination with Nepafenac. |
| Trolamine salicylate | The therapeutic efficacy of Trolamine salicylate can be decreased when used in combination with Nepafenac. |
| Nitroaspirin | The therapeutic efficacy of Nitroaspirin can be decreased when used in combination with Nepafenac. |
| Aloxiprin | The therapeutic efficacy of Aloxiprin can be decreased when used in combination with Nepafenac. |
| Guacetisal | The therapeutic efficacy of Guacetisal can be decreased when used in combination with Nepafenac. |
| Carbaspirin calcium | The therapeutic efficacy of Carbaspirin calcium can be decreased when used in combination with Nepafenac. |
| Choline salicylate | The therapeutic efficacy of Choline salicylate can be decreased when used in combination with Nepafenac. |
| Thiosalicylic acid | The therapeutic efficacy of Thiosalicylic acid can be decreased when used in combination with Nepafenac. |
| Diclofenac | The risk or severity of adverse effects can be increased when Diclofenac is combined with Nepafenac. |
| Flurbiprofen | The risk or severity of adverse effects can be increased when Flurbiprofen is combined with Nepafenac. |
| Bromfenac | The risk or severity of adverse effects can be increased when Bromfenac is combined with Nepafenac. |
| Indomethacin | The risk or severity of adverse effects can be increased when Indomethacin is combined with Nepafenac. |
| Nabumetone | The risk or severity of adverse effects can be increased when Nabumetone is combined with Nepafenac. |
| Tenoxicam | The risk or severity of adverse effects can be increased when Tenoxicam is combined with Nepafenac. |
| Celecoxib | The risk or severity of adverse effects can be increased when Celecoxib is combined with Nepafenac. |
| Tolmetin | The risk or severity of adverse effects can be increased when Tolmetin is combined with Nepafenac. |
| Rofecoxib | The risk or severity of adverse effects can be increased when Rofecoxib is combined with Nepafenac. |
| Piroxicam | The risk or severity of adverse effects can be increased when Piroxicam is combined with Nepafenac. |
| Fenoprofen | The risk or severity of adverse effects can be increased when Fenoprofen is combined with Nepafenac. |
| Valdecoxib | The risk or severity of adverse effects can be increased when Valdecoxib is combined with Nepafenac. |
| Sulindac | The risk or severity of adverse effects can be increased when Sulindac is combined with Nepafenac. |
| Etodolac | The risk or severity of adverse effects can be increased when Etodolac is combined with Nepafenac. |
| Mefenamic acid | The risk or severity of adverse effects can be increased when Mefenamic acid is combined with Nepafenac. |
| Naproxen | The risk or severity of adverse effects can be increased when Naproxen is combined with Nepafenac. |
| Phenylbutazone | The risk or severity of adverse effects can be increased when Phenylbutazone is combined with Nepafenac. |
| Meloxicam | The risk or severity of adverse effects can be increased when Meloxicam is combined with Nepafenac. |
| Carprofen | The risk or severity of adverse effects can be increased when Carprofen is combined with Nepafenac. |
| Suprofen | The risk or severity of adverse effects can be increased when Suprofen is combined with Nepafenac. |
| Salicylic acid | The risk or severity of adverse effects can be increased when Salicylic acid is combined with Nepafenac. |
| Meclofenamic acid | The risk or severity of adverse effects can be increased when Meclofenamic acid is combined with Nepafenac. |
| Oxaprozin | The risk or severity of adverse effects can be increased when Oxaprozin is combined with Nepafenac. |
| Ketoprofen | The risk or severity of adverse effects can be increased when Ketoprofen is combined with Nepafenac. |
| Ibuprofen | The risk or severity of adverse effects can be increased when Ibuprofen is combined with Nepafenac. |
| Lumiracoxib | The risk or severity of adverse effects can be increased when Lumiracoxib is combined with Nepafenac. |
| Magnesium salicylate | The risk or severity of adverse effects can be increased when Magnesium salicylate is combined with Nepafenac. |
| Salsalate | The risk or severity of adverse effects can be increased when Salsalate is combined with Nepafenac. |
| Choline magnesium trisalicylate | The risk or severity of adverse effects can be increased when Choline magnesium trisalicylate is combined with Nepafenac. |
| Antipyrine | The risk or severity of adverse effects can be increased when Antipyrine is combined with Nepafenac. |
| Tiaprofenic acid | The risk or severity of adverse effects can be increased when Tiaprofenic acid is combined with Nepafenac. |
| Etoricoxib | The risk or severity of adverse effects can be increased when Etoricoxib is combined with Nepafenac. |
| Oxyphenbutazone | The risk or severity of adverse effects can be increased when Oxyphenbutazone is combined with Nepafenac. |
| Niflumic acid | The risk or severity of adverse effects can be increased when Niflumic acid is combined with Nepafenac. |
| Nimesulide | The risk or severity of adverse effects can be increased when Nimesulide is combined with Nepafenac. |
| Benoxaprofen | The risk or severity of adverse effects can be increased when Benoxaprofen is combined with Nepafenac. |
| Zomepirac | The risk or severity of adverse effects can be increased when Zomepirac is combined with Nepafenac. |
| Lornoxicam | The risk or severity of adverse effects can be increased when Lornoxicam is combined with Nepafenac. |
| Aceclofenac | The risk or severity of adverse effects can be increased when Aceclofenac is combined with Nepafenac. |
| Zaltoprofen | The risk or severity of adverse effects can be increased when Zaltoprofen is combined with Nepafenac. |
| Azapropazone | The risk or severity of adverse effects can be increased when Nepafenac is combined with Azapropazone. |
| Felbinac | The risk or severity of adverse effects can be increased when Nepafenac is combined with Felbinac. |
| Parecoxib | The risk or severity of adverse effects can be increased when Nepafenac is combined with Parecoxib. |
| Salicylamide | The risk or severity of adverse effects can be increased when Nepafenac is combined with Salicylamide. |
| Kebuzone | The risk or severity of adverse effects can be increased when Nepafenac is combined with Kebuzone. |
| Isoxicam | The risk or severity of adverse effects can be increased when Nepafenac is combined with Isoxicam. |
| Indoprofen | The risk or severity of adverse effects can be increased when Nepafenac is combined with Indoprofen. |
| Ibuproxam | The risk or severity of adverse effects can be increased when Nepafenac is combined with Ibuproxam. |
| Floctafenine | The risk or severity of adverse effects can be increased when Nepafenac is combined with Floctafenine. |
| Fenbufen | The risk or severity of adverse effects can be increased when Nepafenac is combined with Fenbufen. |
| Etofenamate | The risk or severity of adverse effects can be increased when Nepafenac is combined with Etofenamate. |
| Epirizole | The risk or severity of adverse effects can be increased when Nepafenac is combined with Epirizole. |
| Loxoprofen | The risk or severity of adverse effects can be increased when Nepafenac is combined with Loxoprofen. |
| Droxicam | The risk or severity of adverse effects can be increased when Nepafenac is combined with Droxicam. |
| Tolfenamic acid | The risk or severity of adverse effects can be increased when Nepafenac is combined with Tolfenamic acid. |
| Clonixin | The risk or severity of adverse effects can be increased when Nepafenac is combined with Clonixin. |
| Propacetamol | The risk or severity of adverse effects can be increased when Nepafenac is combined with Propacetamol. |
| Tepoxalin | The risk or severity of adverse effects can be increased when Nepafenac is combined with Tepoxalin. |
| Flunixin | The risk or severity of adverse effects can be increased when Nepafenac is combined with Flunixin. |
| Indobufen | The risk or severity of adverse effects can be increased when Nepafenac is combined with Indobufen. |
| Tinoridine | The risk or severity of adverse effects can be increased when Nepafenac is combined with Tinoridine. |
| Alclofenac | The risk or severity of adverse effects can be increased when Nepafenac is combined with Alclofenac. |
| Fentiazac | The risk or severity of adverse effects can be increased when Nepafenac is combined with Fentiazac. |
| Suxibuzone | The risk or severity of adverse effects can be increased when Nepafenac is combined with Suxibuzone. |
| Bumadizone | The risk or severity of adverse effects can be increased when Nepafenac is combined with Bumadizone. |
| Alminoprofen | The risk or severity of adverse effects can be increased when Nepafenac is combined with Alminoprofen. |
| Bufexamac | The risk or severity of adverse effects can be increased when Nepafenac is combined with Bufexamac. |
| Feprazone | The risk or severity of adverse effects can be increased when Nepafenac is combined with Feprazone. |
| Difenpiramide | The risk or severity of adverse effects can be increased when Nepafenac is combined with Difenpiramide. |
| Nifenazone | The risk or severity of adverse effects can be increased when Nepafenac is combined with Nifenazone. |
| Lonazolac | The risk or severity of adverse effects can be increased when Nepafenac is combined with Lonazolac. |
| Tenidap | The risk or severity of adverse effects can be increased when Nepafenac is combined with Tenidap. |
| Bendazac | The risk or severity of adverse effects can be increased when Nepafenac is combined with Bendazac. |
| Pranoprofen | The risk or severity of adverse effects can be increased when Nepafenac is combined with Pranoprofen. |
| Propyphenazone | The risk or severity of adverse effects can be increased when Nepafenac is combined with Propyphenazone. |
| Proglumetacin | The risk or severity of adverse effects can be increased when Nepafenac is combined with Proglumetacin. |
| Ethenzamide | The risk or severity of adverse effects can be increased when Nepafenac is combined with Ethenzamide. |
| Mofebutazone | The risk or severity of adverse effects can be increased when Nepafenac is combined with Mofebutazone. |
| Proquazone | The risk or severity of adverse effects can be increased when Nepafenac is combined with Proquazone. |
| Benorilate | The risk or severity of adverse effects can be increased when Nepafenac is combined with Benorilate. |
| Pirprofen | The risk or severity of adverse effects can be increased when Nepafenac is combined with Pirprofen. |
| Acemetacin | The risk or severity of adverse effects can be increased when Nepafenac is combined with Acemetacin. |